- About Overview
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Org Chart
- Patient Care
In-flight programming features bioartificial kidney
By UCSF School of Pharmacy Editorial Staff / Fri Oct 21, 2011
Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.
Directing this national project and speaking on the airline’s in-flight audio program, Shuvo Roy, PhD, explains the health and economic impacts of the disease, the limitations of dialysis and kidney transplantation, and how UCSF is leading the creation of the two-part device composed of:
- A membrane filter made using silicon nanotechnology to remove toxins from the blood
- A bioreactor that houses specially engineered kidney cells to perform biological functions
Roy is a faculty member in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine.
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.